NextCure
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NextCure and other ETFs, options, and stocks.About NXTC
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines.
CEOMichael S. Richman
CEOMichael S. Richman
Employees43
Employees43
HeadquartersBeltsville, Maryland
HeadquartersBeltsville, Maryland
Founded2015
Founded2015
Employees43
Employees43
NXTC Key Statistics
Market cap44.77M
Market cap44.77M
Price-Earnings ratio-0.53
Price-Earnings ratio-0.53
Dividend yield—
Dividend yield—
Average volume23.74K
Average volume23.74K
High today$12.93
High today$12.93
Low today$12.29
Low today$12.29
Open price$12.86
Open price$12.86
Volume15.14K
Volume15.14K
52 Week high$15.74
52 Week high$15.74
52 Week low$2.69
52 Week low$2.69
Stock Snapshot
NextCure(NXTC) stock is priced at $12.77, giving the company a market capitalization of 44.77M. It carries a P/E multiple of -0.53.
On 2025-12-29, NextCure(NXTC) stock traded between a low of $12.29 and a high of $12.93. Shares are currently priced at $12.77, which is +3.9% above the low and -1.2% below the high.
The NextCure(NXTC)'s current trading volume is 15.14K, compared to an average daily volume of 23.74K.
In the last year, NextCure(NXTC) shares hit a 52-week high of $15.74 and a 52-week low of $2.69.
In the last year, NextCure(NXTC) shares hit a 52-week high of $15.74 and a 52-week low of $2.69.
People also own
Based on the portfolios of people who own NXTC. This list is generated using Robinhood data, and it’s not a recommendation.